Shows
Navigating Swiss Market Access #medtech #digitalhealth🎙️ The Adoption Gap: What the AI for IMPACTS Framework Means for Swiss Market AccessIn this episode, co-hosts Gurmit and Angelina speak with Dr. Christine Jacob, Digital Strategist, Health Tech Researcher, Lecturer at FHNW, and internationally recognised expert in technology adoption in healthcare. With over 20 years of industry experience exploring how social, organisational and technical factors shape the acceptance of digital health tools, Christine brings a unique, science-based perspective on how innovation truly lands in healthcare.Our conversation explores the second half of the reimbursement journey: Adoption. While previous episodes focused on the Assessment phase, such as evaluating digital health technologies through tools like Gurmit’s Value As...
2025-11-2731 minNavigating Swiss Market Access #medtech #digitalhealthSwiss Tariff System: Market Access for Digital Health ApplicationsIn this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs.They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under compulsory health insurance (OKP), a DiGA can only be reimbursed if it fits into a...
2025-10-3022 minNavigating Swiss Market Access #medtech #digitalhealthInvitation to participate in an online survey: Gap Analysis on Swiss Assessment of DHTsAre you a Switzerland-based stakeholder interested in the market access assessment of digital health technologies for the Swiss market? We value your input on how digital health technologies (DHTs) are currently assessed for market access (leading to reimbursement) in Switzerland — particularly by those without deep regulatory expertise. Two webinars will be held in October 2025 to provide context for completing the survey and introduce the key themes behind our research. You can still complete this survey even if you don't attend a webinar. Later in 2026, we will be sharing the results of our study.Â
2025-10-0502 minNavigating Swiss Market Access #medtech #digitalhealthSwiss Patient Leader Insights - Can more be done for Market & Patient Access of DHTs? | Jennifer WoodsJennifer Woods, Swiss Patient Leader and PPI partner, shares how Switzerland can strengthen patient access to digital health technologies: from usability and patient-reported outcomes/experience measures (PROMs & PREMs) to data privacy & security, value-based care, and the daily burden of illness. Beyond highlighting the gaps, she points to solutions — such as integrating patient voices earlier and systematically in HTA processes and aligning market access with real-world patient needs.Jennifer is a Patient Partner for the Swiss Academy of Medical Sciences’ Coordination Platform for Clinical Research (CPCR) and the National Data Stream (NDS) LUCID. She is also an EUPATI Pati...
2025-09-2318 minNavigating Swiss Market Access #medtech #digitalhealthExample of a Health Technology Assessment HTA framework for Digital Health Technologies: Dr. Rosa V HidalgoRosa, Head of HTA at AQuAS (Barcelona), talks about her experience with developing fit-for-purpose assessment frameworks for digital health technologies. She shares how the Spanish HTA network, RedETS, follows a grassroots approach — identifying common needs and building methods that truly capture the value of these innovations. Rosa reflects on how this experience can support better decisions around market access and reimbursement. We also discuss what Switzerland can learn from this approach, offering practical insights for digital health developers and health policy decision-makers.  Recaps in Swiss German & Spanish.  aquas.gencat.cat   | switch to English on thei...
2025-06-2434 minNavigating Swiss Market Access #medtech #digitalhealthInteroperability in Swiss Digital Health: Insights from Dr. Julia Müllner, eHealth SuisseHost Gurmit speaks with Dr. Julia Müllner, Deputy Section Head at eHealth Suisse, about the vital role of interoperability for digital health technologies. From empowering Parkinson’s patients to challenges and strengthening Swiss health IT infrastructure, Julia explains how better data integration can enhance care delivery, improve patient outcomes, and support market access for digital health technologies and their developers. Ensuring both patient and clinician access remains a critical success factor that is addressed from a technological, policy, and healthcare system perspective. 🎧 Bonus: Includes a German-language summary at the end.https://www.e-healt...
2025-05-3026 minNavigating Swiss Market Access #medtech #digitalhealthEpisode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland?In this episode, we explore the reimbursement landscape for digital health technologies (DHTs) in Switzerland with Angelina, offering an introductory overview of key pathways to market access.We focus on the inclusion of DHTs in Switzerland’s compulsory health insurance system ("OKP") and touch on the essential reimbursement criteria—known as the "EAE criteria" or "WZW-Kriterien":Effectiveness (Wirksamkeit)Appropriateness (Zweckmässigkeit)Cost-effectiveness (Wirtschaftlichkeit)We also highlight practical challenges, identify useful public resources and documentation from the Swiss Federal Office of Public Health (FOPH/BAG), and discuss what innovators should consi...
2025-04-2412 minNavigating Swiss Market Access #medtech #digitalhealthEpisode 1 Introducing the Value Assessment Dashboard (VAD) with GurmitIn this debut episode, Gurmit presents his Value Assessment Dashboard (VAD)—a comprehensive tool designed to evaluate digital health technologies across seven key value domains. The VAD helps determine a technology’s potential for reimbursement, market access, and adoption, bridging the gap between innovation and patient access to better healthcare.Developed as part of Gurmit’s MSc Medical Informatics research thesis, the VAD is built upon prior consultancy work in co-developing an orientation guide for assessing digital health technologies (1).The framework serves multiple stakeholders, including startups, insura...
2025-03-2311 minNavigating Swiss Market Access #medtech #digitalhealthMeet your co-hosts & their why | Increasing your confidence on #healthtech market accesWe will be exploring, developing a better understanding, and uncovering strategies & tactics to enhance Swiss market access (reimbursement) for digital health technologies (DHTs), including MedTech and Medical Devices. With our combined expertise in digital health technologies, we’ll invite key stakeholders to share their insights, where we will: a. discuss their challenges, opportunities, and successes in the Swiss market access ecosystem.b. delve into their pain points, constraints, and innovative solutions shaping the future. What you'll gain from listening to our podcast on Swiss Market Access:Valuable insights into Swiss...
2025-02-2303 min